Conversely, reductions in estrogen and BDNF levels have been reported in patients with Parkinson's disease, Alzheimer's disease (AD) (21), postmenopausal women (19), ovariectomized (OVX) mouse models (29, 30), and ER-deficient mouse models (31). This evidence concerns the gene ESR1 and Alzheimer disease.